Form D · Biotechnology

CHONDRIAL THERAPEUTICS HOLDINGS, LLC

Bala Cynwyd, PA · CIK 0001776691

Offering snapshot reported Jan 21, 2020 · SEC filing

Reported sold
Yet to sell
Offering amount: $15M
Investors reported
0
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 21, 2020InitialYet to sellNo comparison0SEC filing
Dec 4, 2019Initial$3,405,000No comparison7SEC filing
May 15, 2019Initial$25,767,611No comparison7SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-358529

Source: Form D, filed Jan 21, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Carole Ben Maimon Director, Executive
John Berman Executive
David Bettoun Executive
Tom Hamilton Director, Executive
Jennifer Johansson Executive
Jonathan Leff Director
Ronald Mark Payne Director
Noreen Scherer Executive
Bryan Sendrowski Director
William Slattery Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
150 Monument Road, Suite 207
Bala Cynwyd, PA, 19004
Phone: 844-511-9056